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Abstract 
We propose a series of methods and models in order to explore the Global Burden of Disease Study 
and the provided healthy life expectancy (HALE) estimates from the World Health Organization 
(WHO) based on the mortality μx of a population provided in a classical life table and a mortality 
diagram. Our estimates are compared with the HALE estimates for the World territories and the 
WHO regions along with providing comparative results with to findings of Chang, Molla, Truman et 
al. (2015) on the “Differences in healthy life expectancy for the US population by sex, race/ethnicity 
and geographic region: 2008 for USA” and from Yong and Saito (2009) regarding “Trends in healthy 
life expectancy in Japan”.  
From the mortality point of view we have developed a simple model for the estimation of a 
characteristic parameter b related to the healthy life years lost to disability and providing full 
application details along with characteristic parameter selection and stability of the coefficients. We 
also provide a direct estimation method of the parameter b from the life tables. We straighten the 
importance of our methodology by proposing and applying estimates of the parameter b by using 
the Gompertz and the Weibull models. 
From the Health State point of view we summarize the main points of the first exit time theory to life 
table data and present the basic models. Even more we develop the simpler 2-parameter health 
state model and an extension of a model expressing the infant mortality to a 4-parameter model 
which is the simpler model providing very good fitting on the logarithm of the force of mortality, 
ln(μx). More important is the use of the Health State Function and the relative impact on mortality to 
find an estimate for the healthy life years lost to disability. 
We have developed simple programs in Excel providing immediately the Life Expectancy, the Loss of 
Healthy Life Years and the Healthy Life Expectancy estimate. 
Keywords:  Health state function, Healthy life expectancy, Mortality Diagram, Loss of healthy life 
years, LHLY, HALE, DALE, World Health Organization, WHO, Global burden of Disease, Health status, 
Gompertz, Weibull. 
 
1. Introduction 
Starting from the late 80’s a Global Burden of Disease (GBD) study was applied in many countries 
reflecting the optimistic views of many researchers and policy makers worldwide to quantify the 
health state of a population or a group of persons. In the time course they succeeded in establishing 
an international network collecting and providing adequate information to calculate health 
measures under terms as Loss of Healthy Life Years (LHLY) or Healthy Life Expectancy (HALE). The 
latter tends to be a serious measure important for the policy makers and national and international 
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health programs. So far the process followed was towards statistical measures including surveys and 
data collection using questionnaires and disability and epidemiological data as well (McDowell, 
2006). They faced many views referring to the definition of health and to the inability to count the 
various health states and of course the different cultural and societal aspects of the estimation of 
health by various persons worldwide. Further to any objections posed when trying to quantify 
health, the scientific community had simply to express with strong and reliable measures that 
millions of people for centuries and thousands of years expressed and continue to repeat every day: 
That their health is good, fair, bad or very bad. As for many decades the public opinion is seriously 
quantified by using well established statistical and poll techniques it is not surprising that a part of 
these achievements helped to improve, establish and disseminate the health state measures. 
However, a serious scientific part is missing or it is not very much explored that is to find the model 
underlying the health state measures. Observing the health state measures by country from 1990 
until nowadays it is clear that the observed and estimated health parameters follow a rather 
systematic way. If so why not to find the process underlying these measures? It will support the 
provided health measures with enough documentation while new horizons will open towards better 
estimates and data validation.  
From the early 90’s we have introduced and applied methods, models and techniques to estimate 
the health state of a population. The related results appear in several publications and we have 
already observed that our estimates are related or closely related to the provided by the World 
Health Organization (WHO) and other agencies as Eurostat or experts as the REVES group. However, 
our method based on a difficult stochastic analysis technique, is not easy to use especially by 
practitioners.  The last four centuries demography and demographers are based on the classical Life 
Tables. Thus here we propose a very simple model based on the mortality μx of a population 
provided in a classical life table. To compare our results with those provided by WHO we use the μx 
included in the WHO abridged life tables. Our estimates are compared with the HALE estimates for 
all the WHO countries. Even more we provide the related simple program in Excel which provides 
immediately the Life Expectancy, the Loss of Healthy Life Years and the Healthy Life Expectancy 
estimate. The comparisons suggest an improved WHO estimate for the majority of the countries. 
There are countries’ results differing from the model and need further study. 
Further Details 
The Global Burden of Disease Study explored the health status of the population of all the countries 
members of the World Health Organization (WHO). It is a large team work started more than 25 
years ago (see Murray and Lopez, 1997,2000, Mathers et al., 2000, Salomon, et al., 2010, 2012, 
Murray et al., 2015, Hausman, 2012, Vos et al., 2012, Robine, Romieu, Cambois, 1999, WHO, 2000, 
2001, 2002, 2004, 2013, 2014 and many other publications). The last years, with the financial 
support of the Bill and Melinda Gates foundation, the work was expanded via a large international 
group of researchers. The accuracy of the data collection methods was improved along with the data 
development and application techniques. So far the health status indicators were developed and 
gradually were established under terms as healthy life expectancy and loss of healthy life years. 
Methods and techniques developed during the seventies and eighties as the Sullivan method 
(Sullivan, 1971) were used quite successfully. Several publications are done with the most important 
included in The Lancet under the terms DALE and HALE whereas a considerable number can be 
found in the WHO and World Bank publications. The same half part of a century several works 
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appear in the European Union exploring the same phenomenon and providing more insight to the 
estimation of the health state of a population and providing tools for the estimation of severe, 
moderate and light disability. The use of these estimates from the health systems and the 
governments is obvious. 
To a surprise the development of the theoretical tools was not so large. The main direction was 
towards to surveys and collection of mass health state data instead of developing and using 
theoretical tools. The lessons learned during the last centuries were towards the introduction of 
models in the analysis of health and mortality. The classical examples are Edmund Halley for Life 
Tables and Benjamin Gompertz for the law of mortality and may others. Today our ability to use 
mass storage tools as the computers and the extensive application of surveys and polls to many 
political, social and economic activities directed the main health state studies. In other words we 
give much attention to opinions of the people for their health status followed by extensive health 
data collection. However, it remains a serious question: can we validate the health status results? As 
it is the standard procedure in science a systematic study as the Global Burden of Disease should be 
validated by one or more models. Especially as these studies are today the main tool for the health 
programs of many countries the need of verification is more important. 
People reply according to their experience. Two main approaches arise: The mortality focus 
approach and the health status approach. Although both look similar responds may have significant 
differences. The main reason is that health is a rather optimistic word opposed to the pessimistic 
mortality term. Twenty years ago we provided a model to express the health state of a population. 
We developed and expanded this model leading to a system providing health status indexes. Here 
we propose several methodologies to estimate the health indexes and to compare with the provided 
by WHO.   
2. The mortality approach 
2.1. The Simplest Model 
We need a simple model to express the health status. The best achievement should be to propose a 
model in which the health measure should be presented by only one main parameter. We thus 
propose a two parameter model with one crucial health parameter: 
   (
 
 
)
 
      (1) 
The parameter T represents the age at which μx=1 and b is a crucial health state parameter 
expressing the curvature of μx. As the health state is improved b gets higher values. 
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Fig. 1. The mortality diagram 
The main task is to find the area Ex under the curve OCABO in the mortality diagram (see Figure 1) 
which is a measure of the mortality effect. This is done by estimating the integral 
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)
 
  
 
 
 
 
     
(
 
 
)
 
 
The resulting value for Ex in the interval [0, T] is given by the simple form: 
           
 
     
 
It is clear that the total information for the mortality is the area provided under the curve μx and the 
horizontal axis. The total area Etotal of the healthy and mortality part of the life span is nothing else 
but the area included into the rectangle of length T and height 1 that is  Etotal=T. The health area is 
given by 
                       
 
     
 
  
   
 
Then a very simple relation arises for the fraction Ehealth/Emortality that is 
       
          
        (2) 
This is the simplest indicator for the loss of health status of a population. As we have estimated by 
another method it is more close to the severe disability causes indicator. 
The relation Etotal/Emortality provides another interesting indicator of the form: 
      
          
     
This indicator is more appropriate for the severe and moderate disability causes indicator (It is 
compatible with our estimates using the health state approach). It provides larger values for the 
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disability measures as the Etotal is larger or the Emortality area is smaller by means that as we live longer 
the disability period becomes larger. 
This method suggests a simple but yet interesting tool for classification of various countries and 
populations, for the loss of healthy life years. A correction multiplier λ should be added for specific 
situations so that the estimator of the loss of healthy life years should be of the form: 
     
      
          
        
However, for comparisons between countries it is sufficient to select λ=1. Even more the selection of 
λ=1 is appropriate when we would like to develop a quantitative measure for the LHLY without 
introducing the public opinion for the health status and the estimates for the cause of diseases and 
other disability measures. From another point of view the influence of the health status of the 
society to the public opinions related to health may cause differences in the values for LHLY 
estimated with the HALE method thus a value for λ larger or smaller than unity is needed. By means 
that we will have to measure not exactly the health status but the public opinion related to the 
health status, the latter leading in a variety of health estimates in connection to socioeconomic and 
political situation along with crucial health information from the mass media. Both measures, the 
standard measure with λ=1 and the flexible one with λ different from 1 could be useful for decision 
makes and health policy administrators and governmental planners.  
To our great surprise our model by selecting λ=1 provided results very close to those provided by 
WHO as it is presented in the following Tables and in other applications. It is clear that we have 
found an interesting estimator for the loss of healthy life years.  
Our idea to find the loss of healthy life years as a fraction of surfaces in a mortality diagram was 
proven to be quite important for expressing the health state measures. A more detailed method 
based on the health state stochastic theory is presented in the book on The Health State Function of 
a Population and related publications (see Skiadas and Skiadas 2010, 2012, 2015) where more health 
estimators are found. 
2.2.1. Application details 
As our method needs life table data we prefer to use full life tables when available. The Human 
Mortality Database is preferred for a number of countries providing full life tables. However, only a 
small part of the world countries are included and thus we also use the abridged life tables provided 
by the World Health Organization. The new abridged life tables from WHO including data from 0 to 
100 years provide good results when applying our method. Instead the previous life tables (0 to 85 
years) are not easily applied. It could be possible to use these life tables by expanding from 85 to 100 
years. For both the abridged and the full life table data we have developed the appropriate models 
and estimation programs in Excel thus make it easy to use.  
2.2.2. Stability of the coefficients of the Simple Model 
Here we discuss some important issues regarding the application of the simple model proposed by 
equation (1). To apply this model to data we use a non-linear regression analysis technique by using 
a Levenberg-Marquardt algorithm. The data are obtained from the WHO database providing 
6       Christos H Skiadas 
 
abridged life tables of the 0-100 years form. The important part of the model is the parameter b 
expressing the loss of healthy life years. Even more b can express the curvature of mortality function 
μx. Applying the model to data we need a measure for the selection of the most appropriate value 
for b.  
2.2.3. When b should be accepted 
The simpler is to find if b follows a systematic change versus age. We start by selecting all the n data 
points (m0, m1,…, mn) for μx to find b and then we select n-1, n-2,…, n-m for a sufficient number of 
m<n. As is presented in Figure 2 the parameter b follows a systematic change. The example is for 
USA males and females the year 2000 and the data are from the full life tables of the Human 
Mortality Database. As it is expected b is larger for females than for males. In both cases a distinct 
maximum value in a specific year of age appears. Accordingly a specific minimum appears for the 
other not so important parameter T (see Figure 3). It is clear that only the specific maximum value 
for b should be selected. Even more the estimates for the maximum b account for a local minimum 
for the first difference dx’ of dx provided from the life table. Next Figure 4 illustrates this case for 
USA males the year 2000 along with a fit curve from our model SK-6. The maximum b is at 94 years 
for males and females the same as for the minimum of the first difference corresponding to the right 
inflection point of the death curve dx. Table I includes the parameter estimates for b and T the year 
2000 for USA males and females. 
 
Fig. 2. Development of the health parameter 
 
Fig. 3. Development of T parameter 
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Fig. 4. First difference (derivative) of dx versus age 
 
TABLE I 
Parameter estimates for the model (USA, 2000) 
Age Females Males   Age Females Males 
Years b T b T   Years b T b T 
71 5.318 147.5 4.975 142.3   91 8.942 110.7 7.992 109.4 
72 5.308 147.5 5.244 136.4   92 9.143 110.0 8.081 109.1 
73 5.296 147.5 5.231 136.4   93 9.224 109.8 8.173 108.8 
74 5.663 140.0 5.459 132.3   94 9.291 109.6 8.218 108.6 
75 5.649 140.0 5.559 130.5   95 9.286 109.6 8.189 108.7 
76 5.905 135.6 5.642 129.2   96 9.263 109.6 8.148 108.8 
77 5.896 135.6 5.736 127.8   97 9.224 109.7 8.094 109.0 
78 6.146 131.9 5.844 126.3   98 9.167 109.9 8.027 109.2 
79 6.280 130.1 5.981 124.5   99 9.093 110.1 7.947 109.4 
80 6.551 126.8 6.214 121.8   100 9.002 110.3 7.856 109.7 
81 6.748 124.6 6.368 120.2   101 8.896 110.6 7.754 110.0 
82 6.972 122.5 6.587 118.2   102 8.775 110.8 7.642 110.3 
83 7.209 120.4 6.774 116.6   103 8.641 111.2 7.521 110.7 
84 7.453 118.5 6.981 115.0   104 8.495 111.5 7.391 111.0 
85 7.710 116.8 7.186 113.6   105 8.339 111.9 7.255 111.4 
86 7.947 115.3 7.378 112.5   106 8.173 112.3 7.114 111.8 
87 8.185 114.0 7.546 111.5   107 8.000 112.7 6.967 112.3 
88 8.369 113.1 7.665 110.9   108 7.822 113.1 6.818 112.7 
89 8.579 112.2 7.826 110.1   109 7.638 113.5 6.666 113.2 
90 8.778 111.3 7.916 109.8   110 7.452 114.0 6.512 113.6 
 
2.3. Estimation without a model (Direct estimation) 
As the needed data sets in the form of mx or qx data are provided from the life tables we have 
developed a method of direct estimation of the loss of healthy life year estimators directly from the 
life table by expanding the life table to the right. 
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The only needed is to estimate the above fraction from the life table data. A similar indicator results 
by selecting the qx data from the life table and using the: 
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In both cases the results are similar as it is presented in the following Figure 5 (A and B). The 
estimates from mx are slightly larger than from qx. In both cases the b estimators growth to a 
maximum at old ages and then decline. The selected b or b+1 indicator for the life years lost from 
birth are those of the maximum value. A smoothing technique averaging over 5 years estimators is 
used to avoid sharp fluctuations in the maximum range area for the direct method. For the Model 
method a simple 3 point averaging gives good results. The maximum HLYL for the direct estimation is 
9.84 for mx and 9.26 for qx. For the Model estimation with mx data the related HLYL is 10.0. As we 
have estimated for other cases both the estimation of the b indicator by this direct method and the 
method by using a model give similar results.   
 
A 
 
B 
 
Fig. 5. Estimation of the HLYL indicator (b) by the direct method and by the simple model (Full results 
A and expanded around the maximum B) 
 
2.4. More details: The Gompertz and the Weibull Distributions 
It should be noted that a more convenient Gompertz (1825) model form is provided by Jacques F. 
Carriere (1992) in the form       
 , where B and c are parameters. This is close to our simple 
model selected.  
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However, we have also selected and applied the following form for the probability density function 
of the Gompertz model: 
    
                                                                                   (4) 
The characteristic parameter expressing the loss of healthy life years is the parameter l. this is also 
demonstrated by observing the cumulative distribution function of the form: 
    
        
The related survival function is 
      
        
The probability density function is: 
     
        
     
 
And the hazard function is  
     
  
  
                            
Thus explaining the above Gompertz form selected (k=l-ln(b)). 
The selected value for the estimation of the healthy life years lost is provided by the parameter l. 
In the same paper Carriere suggests the use the Weibull model. This model has density function (b 
and T are parameters):  
   
 
 
(
 
 
)
   
  (
 
 
)
 
                                                                      (5) 
The Weibull model provides an important form for the hazard function: 
     
 
 
(
 
 
)
   
 
Even more the cumulative hazard is given by: 
     (
 
 
)
 
 
Another important point is that the Cumulative Hazard provided by the Weibull model is precisely 
the form for the simple model presented earlier and the parameter b expresses the healthy life years 
lost. 
3. The Health State Models 
3.1. The Health State Distribution 
Although the health state models are introduced from 1995 (see Janssen and Skiadas, 2015 and 
more publications from Skiadas 2007 and Skiadas and Skiadas 2010, 2012, 2014) few applications 
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appear. The main reason is due to the very laborious first exit time stochastic theory needed and 
that it is assumed that the use of the Gompertz and the Weibull models along with the related 
extensions give enough tools for the practical applications. This is not correct as the first exit time 
stochastic models are produced by using one of the most elegant and accurate methodology to 
model the health-death process as it is demonstrated in the following. The probability distribution of 
the general health state model is of the form: 
   
       
  
 √    
 
 
  
 
     
For the main applications in Demography we can set σ = 1 reducing to the simpler from: 
   
       
  
√    
  
  
 
                                                                             (6) 
While the simpler form arises for the following health state function  
                                                                                    (7) 
That is  
   
              
√    
  
          
                                                                (8) 
The simpler model of this form arises when c = 1 and it is the so-called Inverse Gaussian expressing 
the probability density function for the first exit time of a linearly decaying process: 
   
   
√    
  
       
                                                                    (9) 
Applications of this or similar type forms be can found in Ting Lee and Whitmore (2006) and in Weitz 
and  Fraser (2001). 
The last model as right skewed cannot express the human death process expressed by a highly left 
skewed probability density function. Instead the previous 4-parameter model is applied very 
successfully. Even more this form is very flexible providing very good fitting in the case of high levels 
of infant mortality, as it was the case for time periods some decades ago and also for nowadays 
when infant mortality is relatively low. Two different options arise for the model. That corresponding 
to the health state estimation with the parameter l expressing the high level of the health state and 
represented with the figures 6A and 6C and another form with low levels for the parameter l 
expressing the Infant Mortality (see the figures 6B and 6D). In the latter case the form of the density 
function is: 
   
               
√    
  
          
                                                              (10) 
When the parameter l is very small a 2-parameter model termed here as the Half-Inverse Gaussian 
distribution results: 
   
           
√    
  
      
                                                               (11) 
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The name arises from the similarity of this form with the Half-Normal distribution. 
TABLE II 
Year 2010 2010 2010 1950 1950 1950 
Parameter/R2 
Health 
State 
IM 
Model 
2-
Parameter 
Health 
State 
IM 
Model 
2-
Parameter 
c 5.28 7.91 7.91 4.18 6.26 6.27 
b 0.0192 0.0148 0.0148 0.0239 0.0173 0.0173 
l 13.84 0.0066 - 13.05 0.0314 - 
R2 0.993 0.995 0.993 0.920 0.990 0.927 
 
 
  
A. USA 1950 Females (R2=0.920) B. USA 1950 Females (R2=0.990) 
  
C. USA 2010 Females (R2=0.993) D. USA 2010 Females (R2=0.995) 
 
Fig. 6. The First Exit Time Model-IM including the Infant Mortality applied in USA death probability 
density for females the years 1950 and 2010. 
The advantage of the proposed half-inverse Gaussian or IM-Model for the infant mortality modeling 
is obvious in the case of the application in USA females in 1950. The IM-Model provides a fairly well 
R2=0.990 instead of R2=0.920 for the Health State Model which provides similar results with the 2-
parameter model (see the Table II). The resulting R2 for the year 2010 in USA females are similar as 
the infant mortality is relatively small (see figures 6C and 6D and Table II). 
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3.2. An Important Extension: The simplest IM-Model 
Christel Jennen (1985) suggested a second order approximation to improve the previous model with 
the first order approximation form: 
   
       
  
√    
  
  
 
   
However, we propose and apply here a simpler form adequate for the applications in demography 
data: 
   (
 
√  
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√  
 
 √    
  
        
  
)   
  
 
                                             (12) 
The parameter k expresses the level of the influence of the second order correction term. When k=0 
the last equation form reduces to the first order approximation. The next step is to use the 
expression             presented earlier for H(x) to find the advanced form of IM-model: 
   (
 
√  
) (
              
√  
 
 √                
               
)   
          
                           (13) 
This is the simpler 4-parameter model providing quite well fitting for the logarithm of the force of 
mortality, providing not only good estimates for the infant mortality but also very good estimates for 
all the period of the life time for males and females as is illustrated in Figures 7A-7F. We have thus 
demonstrated that the model proposed in 1995 and the new versions and advanced forms provided 
in several publications and in this paper, approach fairly well the mortality data sets provided by the 
bureau of the census and statistical agencies. This is important in order to straighten the findings 
when applying the first exit time theory to life table data. 
 
3.3. The Health State Function and the relative impact on mortality 
Considering the high importance of the proposed model and the related indicator for the verification 
of the GBD results we proceed in the introduction of a second method based on the health state of 
the population instead of the previous one which was based on mortality. This model was proposed 
earlier (see Skiadas and Skiadas, 2010, 2012, 2013, 2014). These works were based on an earlier 
publication modeling the health state of a population via a first exit time stochastic methodology. 
Here we develop a special application adapted to WHO data provided as abridged life tables (0 to 
100 with 5 year periods). First we expand the abridged life table to full and then we estimate the 
health indicators and finally the loss of healthy life year indicators.  
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A. USA 1933 Males B. USA 1933 Females  
  
C. USA 1950 Males D. USA 1950 Females  
  
E. USA 2010 Males F. USA 2010 Females 
 
Fig. 7. The First Exit Time Model-IM including the Infant Mortality applied in the USA force of 
mortality data in logarithmic form for males and females the years 1933, 1950 and 2010. 
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Fig. 8. The impact of the mortality area to health state  
 
By observing the above graph (Figure 8) we can immediately see that the area between the health 
state curve and the horizontal axis (OMCO) represents the total health dynamics (THD) of the 
population. Of particular importance is also the area of the health rectangle (OABC) which includes 
the health state curve. This rectangle is divided in two rectangular parts the smaller (OAMN) 
indicating the first part of the human life until reaching the point M at the highest level of health 
state (usually the maximum is between 30 to 45 years) and the second part (NMBC) characterized by 
the gradual deterioration of the human organism until the zero level of the health state. This zero 
point health age C is associated with the maximum death rate. After this point the health state level 
appears as negative in the graph and characterizes a part of the human life totally unstable with high 
mortality; this is also indicated by a positively increasing form of the logarithm of the force of 
mortality ln(μx). 
We call the second rectangle NMBC as the deterioration rectangle. Instead the first rectangle OAMN 
is here called as the development rectangle. For both cases we can find the relative impact of the 
area inside each rectangle but outside the health state area to the overall health state. In this study 
we analyze the relative impact of the deterioration area MBCM indicated by dashed lines in the 
deterioration rectangle. It should be noted that if no-deterioration mechanism was present or the 
repairing mechanism was perfect the health state should continue following the straight line AMB 
parallel to the X-axis at the level of the maximum health state. The smaller the deterioration area 
related to the health state area, the higher the healthy life of the population. This comparison can be 
done by estimating the related areas and making a simple division. 
However, when trying to expand the human life further than the limits set by the deterioration 
mechanisms the percentage of the non-healthy life years becomes higher. This means that we need 
to divide the total rectangle area by that of the deterioration area to find an estimate for the “lost 
healthy life years”. It is clear that if we don’t correct the deterioration mechanisms the loss of 
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healthy years will become higher as the expectation of life becomes larger. This is already observed 
in the estimates of the World Health Organization (WHO) in the World Health Report for 2000 where 
the lost healthy years for females are higher than the corresponding values for males. The females 
show higher life expectancy than males but also higher values for the lost healthy years. The 
proposed “loss of healthy life years” indicator is given by: 
MBCM
OABC
MBCM
THD
THD
OABC
LHLY ideal
ideal
 1
 
Where THDideal is ideal total health dynamics of the population and the parameter λ expresses years 
and should be estimated according to the specific case. For comparing the related results in various 
countries we can set λ=1. When OABC approaches the THDideal as is the case of several countries in 
nowadays the loss of healthy life years indicator LHLY can be expressed by other forms. 
Another point is the use of the (ECD) area in improving forecasts especially when using the 5-year 
life tables as is the case of the data for all the WHO Countries. In this case the expanded loss of 
healthy life years indicator LHLY will take the following two forms: 
MBCM
ECDOMCO
LHLY

 2
 
MBCM
ECDOABC
LHLY

 3
 
It is clear that the last form will give higher values than the previous one. The following scheme 
applies: LHLY1<LHLY2<LHLY3. It remains to explore the forecasting ability of the three forms of the 
“loss of healthy life years” indicator by applying LHLY to life tables provided by WHO or by the 
Human Mortality Database or by other sources. 
As for the previous case here important is the loss of health state area MBCM whereas the total area 
including the healthy and non-healthy part is included in OABC+ECD. 
MBCM
ECDOABC
LHLY

 3                                                            (14) 
Details and applications are included in the book on “The Health State Function of a Population”, the 
supplement of this book and other publications (see Skiadas and Skiadas 2010, 2012, 2013, 2016). It 
is important that we can explore the health state of a population by using the mortality approach 
with the Simple Model proposed herewith and the health state function approach as well. The latter 
method provides many important health measures than the simple model.  
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TABLE III 
Comparing WHO (HALE) Results 
Sex/Region 
Healthy Life Expectancy at Birth 
Life Expectancy at Birth 
 (LE) 
2000 2012 2000 2012 
WHO 
(HALE) 
 
Mortality 
Model 
 
HSM 
Model 
WHO 
(HALE) 
Mortality 
Model 
HSM 
Model 
WHO 
 Mortality 
Model 
 
WHO 
Mortality 
Model 
Both sexes combined 
World 58.0 58.4 58.2 61.7 62.5 61.9 66.2 66.2 70.3 70.3 
High income countries 67.3 67.1 67.0 69.8 69.6 69.2 76.0 76.0 78.9 78.9 
African Region 43.1 42.8 42.8 49.6 49.9 49.6 50.2 50.2 57.7 57.7 
Region of the Americas 64.9 65.7 65.4 67.1 67.7 67.2 73.9 73.9 76.4 76.3 
Eastern Mediterranean 
Region 
55.4 56.9 56.6 58.3 59.7 59.4 64.9 64.9 67.8 67.8 
European Region 63.9 63.9 63.9 66.9 67.2 67.0 72.4 72.4 76.1 76.0 
South East Asian Region 54.2 56.3 55.6 58.5 60.6 60.0 62.9 63.0 67.5 67.5 
Western Pacific Region 64.8 63.9 64.2 68.1 67.3 67.5 72.3 72.3 75.9 75.9 
Males 
World 56.4 56.6 56.2 60.1 60.4 60.0 63.9 63.9 68.1 68.0 
High income countries 64.7 64.1 64.2 67.5 67.0 67.0 72.4 72.3 75.8 75.7 
African Region 42.4 41.6 42.3 48.8 48.6 48.6 49.0 49.0 56.3 56.3 
Region of the Americas 62.7 63.1 62.5 64.9 65.1 64.6 70.8 70.8 73.5 73.5 
Eastern Mediterranean 
Region 
54.8 55.7 55.6 57.4 58.2 57.9 63.6 63.6 66.1 66.1 
European Region 60.7 60.4 61.1 64.2 64.3 64.5 68.2 68.2 72.4 72.4 
South East Asian Region 53.5 55.4 54.6 57.4 59.2 58.6 61.6 61.7 65.7 65.7 
Western Pacific Region 63.0 61.8 62.0 66.6 65.2 65.7 70.0 70.0 73.9 73.9 
Females 
World 59.7 60.3 59.9 63.4 64.3 64.1 68.5 68.5 72.7 72.6 
High income countries 70.0 69.7 69.6 72.0 71.8 72.1 79.6 79.5 82.0 81.9 
African Region 43.8 43.8 43.5 50.4 51.2 50.5 51.4 51.4 59.0 59.1 
Region of the Americas 67.2 68.0 67.8 69.1 69.9 69.8 77.0 76.9 79.3 79.2 
Eastern Mediterranean 
Region 
56.1 58.2 57.8 59.2 61.3 61.0 66.4 66.4 69.7 69.6 
European Region 67.1 67.6 67.3 69.6 70.0 69.7 76.7 76.6 79.6 79.6 
South East Asian Region 55.0 57.2 56.4 59.7 62.0 61.7 64.3 64.4 69.4 69.4 
Western Pacific Region 66.7 65.7 66.1 69.8 68.9 69.1 74.8 74.8 78.1 78.0 
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4. Applications 
4.1. Comparative Application for the World and World Regions 
The Table III includes our estimates for the healthy life expectancy at birth for the years 2000 and 
2012 by applying the proposed mortality model and the health state model (HSM), and the 
estimates of WHO referred as HALE and included in the WHO websites (August 2015). Our estimates 
for the mortality model are based on LHLY=(b+1)=Etotal/Emortality. 
The main finding is that our models verify the WHO (HALE) estimates based on the Global Burden of 
Disease Study. Our results are quite close (with less to one year difference) to the estimates for the 
World, the High Income Countries, the African region, the European region and Western Pacific and 
differ by 1-2 years for the Eastern Mediterranean region and the South East Asian region. In the last 
two cases the collection of data and the accuracy of the information sources may lead to high 
uncertainty of the related health state estimates. This is demonstrated in the provided confidence 
intervals for the estimates in countries of these regions in the studies by Salomon et al. (2012) and 
the Report of WHO (2001) for the HLE of the member states (2000). From the Salomon et al. study 
we have calculated a mean confidence interval of 5.5 years for males and 6.8 for females for the 
year 2000. We thus propose to base the future works on the system we propose and to use it to 
calibrate the estimates especially for the countries providing of low accuracy data. 
To support future studies we have formulated an easy to use framework in Excel. The only needed is 
to insert data for μx in the related column of the program. The program estimates the life 
expectancy, the loss of healthy life years and the healthy life expectancy.  
 
4.2. Application to USA 2008 
Both the Gompertz and the Weibull health estimators (section 2.4) are calculated by the appropriate 
computer program. The results are compared with those of the methods proposed earlier thus 
providing enough evidence for a successful application. The estimates of the WHO are also included 
in the related table. The task to find an alternative of the WHO and other estimates for the Healthy 
Life Years Lost is highly supported by using a series of methods leading to similar and easily 
reproducible results. 
Only few detailed publications appear in order to use for comparative applications. It is highly 
appreciated that one paper by Chang et al. for USA data for 2008 and of Yong and Saito (2009) on 
healthy life expectancy in Japan: 1986 – 2004, published in Demographic Research are of particular 
importance for our comparative applications. 
A very important paper by Chang et al. (2015) appeared in the Journal of Public Health. It includes 
calculations of the Life Expectancy (LE) and the Healthy Life Expectancy (HLE) for the United States 
population the year 2008 by sex and race/ethnicity. 
Our task was to find good estimates compared to the authors’ results by a different methodology 
than the survey data collection and the Sullivan method followed. Following the above provided 
models and estimation techniques, three different methods are selected to estimate the HLE from 
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only the life table data sets (mortality data). The benefits are: Simple estimation, estimates for all 
the period where mortality data exist, comparison with existing estimates from other methods, fix 
the weights needed for other measurements, provide a simple methodology for health decision 
makers to organize future plans. As an example the estimates for USA (1950) are LE (68.0 years) and 
HLE (61.3 years). 
We have calculated similar results for the first part of the Table 1 of the Chang et al. paper related to 
all races and for both sexes, male and female (see our Table IV). A power model, a Weibull model 
and a Gompertz model are used to first estimate the Healthy Life Years Lost (HLYL) and then find the 
Healthy Life Expectancy (HLE) from the simple relation HLE=LE-HLYL. We have verified that our 
results are within the provided “plausibility range” suggested by Chang et al. and very close to their 
estimates for all the life period. 
Instead for the second part of Table 1 of the authors our estimates differ considerably from the 
related figures provided. Specifically for “Hispanic” we have estimated 8.9 HLYL corresponding to 
72.1 HLE instead of 13.4 (67.6 HLE) of the authors and for “Non-Hispanic black” we estimated 7.0 
HLYL (66.7 HLE) instead of 12.3 (61.4 HLE) of the authors. The other estimates for “Non-Hispanic 
white” 7.9 HLYL (70.5 HLE) of the authors is in agreement with our estimates of 8.3 HLYL (70.1 HLE).  
It is important to clarify the cause of the differences as the perfect agreement between both 
methods will straighten the HLE estimators.  
We have provided the related estimation programs in the webpage 
http://www.smtda.net/demographics2016.html  to support comparative applications. 
 
4.3. Application in Japan 1986-2004 
The results from Yong and Saito (2009) on healthy life expectancy in Japan: 1986 – 2004, published 
in Demographic Research are used for our comparative applications. The authors applied the 
Sullivan method to data collected from a large national survey in Japan. The number of responders 
and the methodology applied assures relatively good results adequate for a comparative study. 
Especially the part of the study related to not so poor and poor state of health was selected for our 
comparisons. This is because our theory presented above suggests the estimation of the health state 
as a fraction of areas related to mortality and health as it is presented in Figure 1 and the related 
theory. The impact on the public opinion regarding the health state is due to the Ehealth, the Emortality 
and the total Health-Mortality area Etotal. The impact is expressed by the exponent b or b+1 
depending on the form of the social status of the society and the male-female differentiation 
regarding the adoption and spread of the information for health, disability and mortality.  
We apply the Direct Estimation as presented above in Japan from 1947 to 2012 for mx and qx data 
included in the full life tables provided by the Human mortality Database (HMD) thus estimating the 
parameters b and b+1 as is illustrated in Figure 9 for Japan (males). In the same Figures we also have 
included the Healthy Life Years Lost (HLYL) from the HALE estimates of the World Health 
Organization. Although the results for the years 1990, 2000a, 2010, 2012 and 2013 are within the 
region defined by the four curves, there are significant differences in the estimates in 2000b, 2001, 
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2002 and 2007 underestimating the HLYL due to improvements in the methodology and the use of 
new epidemiological data. In the Annex Table of the World Health Report 2001 and the related of 
2002 write:  
Healthy life expectancy estimates published here are not directly comparable to those published in 
the World Health Report 2000, due to improvements in survey methodology and the use of new 
epidemiological data for some diseases. See Statistical Annex notes (pp.130–135). The figures 
reported in this Table along with the data collection and estimation methods have been largely 
developed by WHO and do not necessarily reflect official statistics of Member States. Further 
development in collaboration with Member States is underway for improved data collection and 
estimation methods (WHO 2001). 
Healthy life expectancy estimates published here are not directly comparable to those published in 
The World Health Report 2001, because of improvements in survey methodology and the use of new 
epidemiological data for some diseases and revisions of life tables for 2000 for many Member States 
to take new data into account (see Statistical Annex explanatory notes). The figures reported in this 
Table along with the data collection and estimation methods have been largely developed by WHO 
and do not necessarily reflect official statistics of Member States. Further development in 
collaboration with Member States is under way for improved data collection and estimation methods 
(WHO 2002). 
 
Figure 10 illustrates the healthy life years lost for females in Japan following the same procedure as 
for males. As before significant differences appear especially for the years 2002 and 2007. Even 
more it is clear that the differences not following a clear trend are due to the ongoing process of the 
estimation team of WHO to arrive in a best estimate method. To this end the recently provided 
estimates for 2000a, 2012 and 2013 (presented without decimal points) for males and females are 
closer to the results from our methodology.  
 
 
Fig. 9. Comparing the HLYL with a direct method to the WHO estimates (Japan, males) 
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Fig. 10. Comparing the HLYL with a direct method to the WHO estimates (Japan, females) 
Figures 11A – 11H illustrate the expected number of years in poor health for 25, 45, 65 and 85 years 
men and women following the Yong-Saito findings and the direct application results based on mx and 
qx estimates included in Tables VI and V (see end of the paper for these Tables and Figures 11A-11H). 
For both cases (men and women) the majority of the Yong-Saito estimates are within the interval 
suggested with our calculations. As for both men and women the Yong-Saito findings suggest a 
declining pattern for the healthy life years lost until 1995, followed by an increasing trend not 
explained by significant variations of the mortality trends or of the life expectancy, we have to 
explore socioeconomic factors influencing the responses to questionnaires and in a second stage the 
changes in the health state of a population. So, huge changes in LHLY could be expected to arise in 
very special morbidity cases as from the spread of epidemics. Instead the growing unemployment 
rate in Japan leading to a maximum in 2004 along with the slowdown of the economy and the 
related economic indicators can explain the relative changes in the public opinion regarding the 
health state. After all as the surveys cover 280,000 households and data on over 750,000 individuals 
were collected, the uncertainty degree should be very low. Specific sociological surveys are needed 
to explore the influence of socioeconomic and political factors not only to the health state but to the 
way the responders reply to a specific questionnaire.  
5. Discussion and Conclusions 
The GBD study critisized by Williams (see Murray et al. 2000) whereas many comments from people 
from social sciences and philosophy refer to the impossibility to define health and, as a 
consequence, to measure it. The main problem is that we cannot have flexibility in finding an 
estimate of health the way we do with other measures of the human organism and related activities. 
So far if we measure health by collecting surveys it is clear that the uncertainty is relatively high. 
Even more if we decide for an accepted health state estimate (see Sanders, 1964 and related studies 
during 60’s and 70’s) it remains the problem of accepting a unit of measure.  The quantitative 
methods we propose overcome many of the objections posed. That we have achieved is to propose 
and apply several quantitative methods and techniques leading to estimates of the healthy life years 
lost, that more than to be close to the WHO results, provide enough evidence for estimating and 
quantifying the health state of a population.  
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Table IV. Comparing Chang et al.  estimates 
 
  
Age
LE Plausibility LE Plausibility LE Plausibility
(Years) Pub Pub SK W G Range Pub SK W G Pub Pub SK W G Range Pub SK W G Pub Pub SK W G Range Pub SK W G
<1 78.1 69.3 68.9 69.7 69.8 (68.4–70.3) 8.8 9.2 8.4 8.3 75.6 67.6 66.8 67.7 67.9 (66.8–69.2) 8.0 8.8 7.9 7.7 80.6 70.9 70.7 71.2 71.4 (69.8–72.6) 9.7 9.9 9.4 9.2
1–4 77.6 68.7 68.4 69.2 69.3 (67.9–69.8) 8.9 9.2 8.4 8.3 75.1 67.1 66.3 67.2 67.4 (66.1–68.5) 8.0 8.8 7.9 7.7 80.1 70.3 70.2 70.7 70.9 (69.1–71.8) 9.8 9.9 9.4 9.2
5–9 73.7 64.9 64.6 65.3 65.5 (64.1–66.0) 8.8 9.1 8.4 8.2 71.2 63.2 62.5 63.3 63.5 (62.2–64.6) 8.0 8.7 7.9 7.7 76.1 66.5 66.2 66.8 66.9 (65.2–67.9) 9.6 9.9 9.3 9.2
10–14 68.8 60.0 59.7 60.5 60.6 (59.2–61.1) 8.8 9.1 8.3 8.2 66.3 58.4 57.6 58.5 58.7 (57.4–59.7) 7.9 8.7 7.8 7.6 71.2 61.6 61.4 61.9 62.1 (60.4–63.0) 9.6 9.8 9.3 9.1
15–19 63.8 55.1 54.8 55.6 55.7 (54.4–56.2) 8.7 9.0 8.2 8.1 61.3 53.5 52.7 53.6 53.8 (52.6–54.8) 7.8 8.6 7.7 7.5 66.2 56.7 56.5 57.1 57.2 (55.5–58.1) 9.5 9.7 9.1 9.0
20–24 59.0 50.4 50.2 50.9 51.1 (49.7–51.5) 8.6 8.8 8.1 7.9 56.6 48.8 48.2 49.0 49.2 (47.9–50.1) 7.8 8.4 7.6 7.4 61.3 52.0 51.8 52.3 52.5 (50.8–53.3) 9.3 9.5 9.0 8.8
25–29 54.3 45.9 45.7 46.4 46.6 (45.2–46.9) 8.4 8.6 7.9 7.7  52.0 44.4 43.8 44.6 44.8 (43.5–45.6) 7.6 8.2 7.4 7.2 56.5 47.3 47.2 47.8 47.9 (46.2–48.6) 9.2 9.3 8.7 8.6
30–34 49.5 41.4 41.2 41.9 42.0 (40.7–42.3) 8.1 8.3 7.6 7.5 47.3 39.9 39.4 40.2 40.3 (39.1–41.1) 7.4 7.9 7.1 7.0 51.6 42.7 42.6 43.1 43.3 (41.7–44.0) 8.9 9.0 8.5 8.3
35–39 44.8 36.8 36.8 37.5 37.6 (36.2–37.8) 8.0 8.0 7.3 7.2 42.6 35.4 35.0 35.7 35.9 (34.7–36.6) 7.2 7.6 6.9 6.7 46.8 38.2 38.2 38.7 38.8 (37.2–39.4) 8.6 8.6 8.1 8.0
40–44 40.1 32.5 32.5 33.1 33.3 (31.9–33.4) 7.6 7.6 7.0 6.8 38.0 31.0 30.7 31.4 31.6 (30.3–32.2) 7.0 7.3 6.6 6.4 42.0 33.8 33.8 34.2 34.4 (32.9–34.9) 8.2 8.2 7.8 7.6
45–49 35.5 28.3 28.3 28.9 29.0 (27.8–29.2) 7.2 7.2 6.6 6.5 33.5 26.9 26.6 27.3 27.5 (26.3–28.0) 6.6 6.9 6.2 6.0 37.3 29.6 29.5 30.0 30.1 (28.7–30.7) 7.7 7.8 7.3 7.2
50–54 31.0 24.3 24.3 24.8 24.9 (23.8–25.1) 6.7 6.7 6.2 6.1 29.1 22.9 22.7 23.3 23.4 (22.4–24.0) 6.2 6.4 5.8 5.7 32.8 25.5 25.5 25.9 26.1 (24.8–26.6) 7.3 7.3 6.9 6.7
55–59 26.8 20.6 20.6 21.1 21.2 (20.2–21.4) 6.2 6.2 5.7 5.6 25.0 19.3 19.1 19.7 19.8 (18.8–20.3) 5.7 5.9 5.3 5.2 28.4 21.8 21.7 22.1 22.2 (21.1–22.7) 6.6 6.7 6.3 6.2
60–64 22.7 17.2 17.0 17.5 17.6 (16.8–17.9) 5.5 5.7 5.2 5.1 21.0 16.0 15.6 16.1 16.3 (15.5–16.9) 5.0 5.4 4.9 4.7 24.1 18.2 18.0 18.3 18.4 (17.6–19.1) 5.9 6.1 5.8 5.7
65–69 18.8 14.0 13.8 14.2 14.3 (13.7–14.7) 4.8 5.0 4.6 4.5 17.3 13.0 12.5 13.0 13.1 (12.6–13.8) 4.3 4.8 4.3 4.2 20.0 14.9 14.6 14.9 15.0 (14.3–15.7) 5.1 5.4 5.1 5.0
70–74 15.2 11.1 10.8 11.2 11.3 (10.8–11.7) 4.1 4.4 4.0 3.9 13.9 10.2 9.8 10.1 10.2 (9.9–11.0) 3.7 4.1 3.8 3.7 16.2 11.7 11.5 11.7 11.8 (11.3–12.5) 4.5 4.7 4.5 4.4
75–79 11.8 8.4 8.1 8.4 8.5 (8.2–9.0) 3.4 3.7 3.4 3.3 10.7 7.7 7.2 7.6 7.6 (7.5–8.4) 3.0 3.5 3.1 3.1 12.6 8.9 8.7 8.9 8.9 (8.6–9.6) 3.7 3.9 3.7 3.7
80–84 8.9 6.1 6.0 6.2 6.3 (6.0–6.7) 2.8 2.9 2.7 2.6 8.0 5.5 5.3 5.5 5.6 (5.3–6.1) 2.5 2.7 2.5 2.4 9.5 6.6 6.4 6.5 6.6 (6.4–7.2) 2.9 3.1 3.0 2.9
85+ 6.4 4.3 4.3 4.5 4.5 (4.3–4.8) 2.1 2.1 1.9 1.9 5.7 3.7 3.7 3.9 3.9 (3.6–4.3) 2.0 2.0 1.8 1.8 6.8 4.6 4.6 4.7 4.7 (4.5–5.1) 2.2 2.2 2.1 2.1
Pub: Chang et al. estimates SK: Skiadas model estimates W: Weibull estimates HLE-G: Gompertz estimates
HLE HLYL HLE HLYL HLE HLYL
Life Expectancy (LE) Healthy Life Expectancy (HLE) and Healthy Life Years Lost (HLYL) by sex for the United States Population, 2008*
FemaleBoth sexes Male
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TABLE V 
 
 
 
Yong-Saito mx(b+1) qx(b+1) mx(b) qx(b)
1986 75.3 8.3 8.0 7.3 7.0
1989 76.0 8.5 8.2 7.5 7.2
1992 76.1 8.6 8.2 7.6 7.2
1995 76.4 8.8 8.3 7.8 7.3
1998 77.2 8.8 8.3 7.8 7.3
2001 78.0 8.8 8.4 7.8 7.4
2004 78.6 8.9 8.4 7.9 7.4
1986 51.4 7.2 7.8 7.5 6.9 6.5
1989 52.0 7.2 8.0 7.6 7.0 6.7
1992 52.1 6.3 8.0 7.7 7.1 6.7
1995 52.3 5.7 8.2 7.8 7.2 6.8
1998 53.0 6.9 8.2 7.7 7.2 6.8
2001 53.8 7.7 8.3 7.8 7.3 6.9
2004 54.3 8.0 8.3 7.9 7.4 6.9
1986 32.4 5.7 6.5 6.3 5.8 5.5
1989 32.9 5.9 6.7 6.4 5.9 5.6
1992 33.0 5.0 6.7 6.4 6.0 5.7
1995 33.3 4.6 6.9 6.5 6.1 5.7
1998 34.0 5.5 6.9 6.5 6.1 5.7
2001 34.8 6.2 6.9 6.6 6.1 5.8
2004 35.3 6.5 7.0 6.6 6.2 5.8
1986 15.9 3.8 4.6 4.0 4.4 3.8
1989 16.2 3.9 4.7 4.1 4.5 3.9
1992 16.3 3.4 4.7 4.2 4.5 4.0
1995 16.5 3.1 4.8 4.3 4.6 4.0
1998 17.1 3.8 4.8 4.3 4.5 4.0
2001 17.8 4.4 4.9 4.3 4.6 4.1
2004 18.2 4.7 4.9 4.3 4.6 4.1
1986 4.8 1.4 1.9 1.7 1.8 1.6
1989 4.9 1.5 1.9 1.7 1.9 1.6
1992 4.9 1.2 2.0 1.7 1.9 1.6
1995 5.1 1.1 2.0 1.8 1.9 1.7
1998 5.5 1.6 2.0 1.8 1.9 1.7
2001 5.9 2.1 2.0 1.8 1.9 1.7
2004 6.1 2.3 2.0 1.8 1.9 1.7
Expected number of years in poor healthLife 
Expectancy
Year
Life expectancy and healthy life expectancy for Japanese men, 1986-2004
25 year old men
At birth men
45 year old men 
65 year old men 
85 year old men 
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TABLE VI 
 
 
 
Yong-Saito mx(b+1) qx(b+1) mx(b) qx(b)
1986 81.0 10.0 9.7 9.0 8.7
1989 81.8 10.3 9.9 9.3 8.9
1992 82.3 10.4 10.0 9.4 9.0
1995 82.8 10.5 10.1 9.5 9.1
1998 83.9 10.5 10.1 9.5 9.1
2001 84.9 10.7 10.3 9.7 9.3
2004 85.5 10.8 10.3 9.8 9.3
1986 56.7 9.8 9.4 9.1 8.4 8.1
1989 57.5 9.8 9.6 9.3 8.7 8.3
1992 57.9 8.8 9.7 9.3 8.8 8.4
1995 58.6 8.0 9.8 9.4 8.9 8.5
1998 59.6 9.8 9.8 9.4 8.9 8.5
2001 60.5 11.0 10.0 9.6 9.1 8.6
2004 61.1 11.2 10.1 9.6 9.1 8.7
1986.0 37.4 8.0 7.9 7.6 7.1 6.8
1989.0 38.1 8.2 8.1 7.8 7.3 7.0
1992.0 38.5 7.2 8.1 7.8 7.4 7.1
1995.0 39.1 6.6 8.2 7.9 7.4 7.1
1998.0 40.2 8.0 8.2 7.9 7.4 7.1
2001.0 41.0 9.0 8.4 8.0 7.6 7.3
2004.0 41.6 9.2 8.5 8.1 7.7 7.3
1986 19.3 5.2 5.5 5.3 5.0 4.8
1989 20.0 5.4 5.6 5.4 5.1 4.9
1992 20.3 4.9 5.7 5.5 5.1 4.9
1995 20.9 4.6 5.7 5.5 5.2 5.0
1998 22.0 5.6 5.7 5.5 5.2 5.0
2001 22.7 6.6 5.9 5.6 5.3 5.1
2004 23.3 6.8 5.9 5.7 5.4 5.1
1986 5.7 1.7 2.3 2.2 2.1 2.0
1989 6.0 1.8 2.3 2.3 2.1 2.0
1992 6.1 1.7 2.4 2.3 2.1 2.0
1995 6.7 1.8 2.4 2.3 2.2 2.1
1998 7.4 2.2 2.4 2.3 2.2 2.1
2001 7.8 3.1 2.4 2.3 2.2 2.1
2004 8.1 3.1 2.5 2.3 2.2 2.1
Life expectancy and healthy life expectancy for Japanese women, 1986-2004
Year
Life 
Expectancy
Expected number of years in poor health
85 year old w omen 
At birth men
25 year old w omen
45 year old w omen 
65 year old w omen 
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Fig. 11(A-H). Expected number of years in poor health for 25, 45, 65 and 85 years men and women 
(Yong-Saito findings and direct application results based on mx and qx)  
